Critical Care PCD Franchise India — 273+ WHO-GMP Certified Injectable Formulations
Biofril Healthcare’s flagship Critical Care division comprises a comprehensive WHO-GMP certified injectable portfolio for Intensive Care Units, hospitals, and tertiary care institutions. Submit an application for monopoly Propaganda-cum-Distribution (PCD) franchise allocation in your district with end-to-end inventory, promotional, and regulatory documentation support.
Submit Critical Care Franchise ApplicationIndia’s Most Rapidly Expanding Hospital Injectable Segment
Hospital and Intensive Care Unit pharmaceuticals represent the fastest-growing segment of the Indian pharmaceutical market, driven by rising chronic disease burden, expansion of tertiary care infrastructure, and sustained government investment in critical care access. The Biofril Critical Care division has been engineered specifically for PCD franchise partners targeting hospital procurement, ICU pharmacy supply, and institutional tender contracts.
- 273+ WHO-GMP certified injectable formulations spanning anti-infectives, antimalarials, antioxidants, pain management, neurology, gastrointestinal, and hormones
- WHO-GMP certified manufacturing with documented Standard Operating Procedures, in-house Quality Control laboratory, and ICH-compliant stability data
- Hospital-grade packaging configurations: vials, ampoules, lyophilised injections, and infusion bag preparations
- Monopoly territorial allocation per district documented in franchise agreement
- Promotional support package: visual aids, Medical Representative kits, doctor sample packs, and scientific literature
- Expedited dispatch from Nalagarh manufacturing facility, with cold-chain logistics where therapeutically indicated
- Hospital tender documentation: Certificates of Analysis, WHO-GMP certificates, and regulatory dossiers prepared on request
Hospital Injectable Categories We Manufacture
- Anti-Infective Agents: Meropenem, Cefepime, Cefoperazone-Sulbactam, Piperacillin-Tazobactam, Imipenem-Cilastatin, Amikacin, Vancomycin, Teicoplanin, Tigecycline
- Antimalarials: Artesunate injectable, Artemether, Quinine parenteral
- Neurology: Phenytoin, Levetiracetam, Magnesium Sulphate, Citicoline, Cerebroprotein hydrolysate
- Pain Management: Tramadol, Diclofenac Sodium, Paracetamol IV, Ketorolac, Hydrocortisone
- Gastrointestinal & Antiulcerants: Pantoprazole, Esomeprazole, Rabeprazole, Ondansetron
- Antioxidants and Vitamins: Glutathione, Ascorbic Acid (Vitamin C), B-Complex, Vitamin K, Cholecalciferol
- Hormones and Steroids: Hydrocortisone Sodium Succinate, Dexamethasone, Methylprednisolone, Hydroxyprogesterone
- Infusion Preparations: Sodium Chloride 0.9%, Dextrose-Normal Saline (DNS), Ringer Lactate variants
Five-Step Application to Activation
- Step 1 — Enquiry Submission: Communicate target district, current Propaganda-cum-Distribution experience, and intended therapeutic categories. Response within 24 business hours including a commercial proposal.
- Step 2 — Franchise Agreement Execution: Sign the monopoly PCD franchise agreement specifying territorial allocation, minimum monthly procurement commitment, and supply terms.
- Step 3 — Initial Order Placement: Configure inaugural order across the 273+ SKU portfolio. Payment terms: 50% advance, 50% prior to dispatch.
- Step 4 — Promotional Kit Dispatch: Receive promotional materials, doctor sample packs, scientific literature, and net pricing schedules.
- Step 5 — Market Activation: Commence hospital and prescriber outreach. Replenishment orders as commercial activity scales.
Submit Critical Care PCD Application
Territories available across India. Monopoly district allocation. Submit your application with district and operational details.
FAQs — Critical Care PCD
What is BIOFRIL HEALTHCARE’s minimum order quantity for PCD franchise?
Minimum order quantity varies by division and product category. Critical Care injectables typically start at 50 units per SKU; general range tablets/capsules from 100 strips per SKU. Our business development team confirms specific MOQ in the commercial proposal.
Does BIOFRIL HEALTHCARE provide monopoly district allocation for PCD franchise partners?
Yes. All PCD franchise agreements document monopoly territorial allocation at district level. Once a district is allocated to a franchise partner, BIOFRIL HEALTHCARE will not appoint another PCD partner in the same district for the duration of the agreement.
What promotional support does BIOFRIL HEALTHCARE provide to PCD franchise partners?
The promotional kit includes visual aids, Medical Representative kits, doctor sample packs, scientific literature, pricing schedules, and product brochures. Marketing materials are dispatched along with the inaugural franchise order.
What are the payment terms for the inaugural PCD franchise order?
Standard payment terms are 50% advance with the purchase order and the remaining 50% prior to dispatch. Subsequent replenishment orders may be eligible for revised terms based on commercial track record.
Which certifications does BIOFRIL HEALTHCARE hold?
BIOFRIL HEALTHCARE holds WHO-GMP, ISO 9001:2015, FSSAI Central License (No. 13026999000031), HACCP, and AYUSH manufacturing licenses. Drug License: WLF21B2026CH000085 (valid through March 2031). All certifications available for review during partnership due diligence.
How does BIOFRIL HEALTHCARE handle hospital tender supply documentation?
Hospital and institutional tender documentation including Certificates of Analysis, WHO-GMP certificates, ISO certificates, stability data, and regulatory dossiers is prepared in advance and provided to franchise partners on request for tender submission support.
Explore Other Divisions & Territories
Critical Care PCD →
273+ WHO-GMP injectable formulations for ICU and tertiary care institutions.
General Range PCD →
200+ tablets, capsules, syrups across AZOT, SIGMA, and STRAUSSWELL marketing brands.
Nutraceutical PCD →
95+ FSSAI-licensed wellness formulations. PCD + private-label contract manufacturing.
Herbal & Ayurvedic PCD →
150+ AYUSH classical and patent formulations under VISHAKHAA HERBALS brand.
Anti-Infectives Therapy →
Carbapenems, cephalosporins, glycopeptides, aminoglycosides, polymyxins.
Cardiac & Diabetic Therapy →
Antihypertensives, statins, antidiabetics, combination preparations.
Chandigarh / Punjab / Haryana →
Districts available across North India\’s most concentrated pharmaceutical market.
Himachal Pradesh →
Local advantage — same-day dispatch from our Nalagarh manufacturing facility.
Frequently asked questions about Critical Care PCD Franchise
Common questions from PCD partners, distributors, and procurement teams. Click each to expand.
What is critical care PCD franchise?
A critical care PCD franchise is a B2B distribution arrangement where a pharmaceutical manufacturer like BIOFRIL HEALTHCARE grants a partner monopoly rights to market and distribute critical care injectables (carbapenems, antibiotics, vasopressors, anticoagulants, electrolytes) in a specified district or state. The franchise partner buys at factory price and sells to hospitals, nursing homes, ICU procurement teams.
How much investment is required for critical care PCD franchise in India?
Critical care PCD franchise investment typically ranges from INR 1.5 lakh to INR 5 lakh for initial stock and registrations. BIOFRIL HEALTHCARE works with partners starting at INR 1 lakh first-order value with no franchise fee.
Which is the best critical care PCD pharma company in India?
The best critical care PCD pharma company has: WHO-GMP + ISO 9001:2015 certification, direct factory ownership (not a middleman), 300+ critical care SKUs, monopoly district allocation in writing, 96%+ on-time dispatch, and complete tender paperwork support. BIOFRIL HEALTHCARE meets all 6 criteria with our Nalagarh manufacturing plant.
What products are in the critical care range?
Our critical care range includes carbapenems (FARAMERO Meropenem 250/500/1000mg), beta-lactam combinations (ZUCOLI Piperacillin-Tazobactam, RILCEFTA Cefoperazone+Sulbactam), aminoglycosides (FRILKACIN Amikacin), anticoagulants (FARAHEP Heparin, ENOXFRIL Enoxaparin), corticosteroids (BFHC Hydrocortisone, SV-MPSS Methylprednisolone), tranexamic acid (BF-ETEREN), neuroprotectives (CINCITI Citicoline).
Do you provide monopoly rights in critical care PCD?
Yes — BIOFRIL HEALTHCARE provides written monopoly rights for the critical care division at the district level. No competing PCD partner is appointed for the same product list in that district for the duration of the contract.
What documents are needed to start critical care PCD franchise?
You need: Drug License (Form 20B + 21B for wholesale), GST registration, PAN, current account, and a basic office/warehouse for stock storage. We provide manufacturer documents (WHO-GMP, ISO, PMA, CoA, stability data) for your tender bids.